Clinical Trials Sponsored by Vicuron Pharmaceuticals
Total 19621 results
-
Endo PharmaceuticalsCompletedEdematous SkinUnited States
-
Inovio PharmaceuticalsCompletedHuman Papillomavirus (HPV) | Vulvar Dysplasia | Vulvar Intraepithelial Neoplasia (VIN) | Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) | VIN2 | VIN3 | Pre-cancerous Lesions of the VulvaUnited States
-
Ferring PharmaceuticalsCompletedControlled Ovarian SimulationKorea, Republic of, Taiwan, China, Vietnam
-
Syndax PharmaceuticalsActive, not recruitingChronic Graft-versus-host-diseaseKorea, Republic of, United States, Spain, Taiwan, France, Singapore, Belgium, Germany, Italy, Canada, Israel, Australia, United Kingdom, Greece, Poland, Portugal
-
Ferring PharmaceuticalsCompletedEndometriosis-related PainUnited States
-
Regeneron PharmaceuticalsTerminatedParoxysmal Nocturnal HemoglobinuriaUnited States
-
Syndax PharmaceuticalsActive, not recruitingChronic Graft-versus-host-diseaseUnited States
-
Endo PharmaceuticalsCompletedHypogonadotropic Hypogonadism | Hypogonadism | Hypogonadism, MaleUnited States
-
Regeneron PharmaceuticalsCompleted
-
Actinium PharmaceuticalsCompleted
-
Actinium PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia | Leukemia, Myeloid, Acute | AML | Acute Myelogenous Leukemia | Bone Marrow Transplant | Myelogenous Leukemia, Acute | Myeloid Leukemia, Acute | Leukemia, Acute Myelogenous | Leukemia, Acute MyeloidUnited States, Canada
-
Santhera PharmaceuticalsCompletedFriedreich's AtaxiaUnited States
-
Regeneron PharmaceuticalsAvailableDiffuse Large B-Cell Lymphoma (DLBCL) | Relapsed or Refractory (R/R) Follicular Lymphoma (FL) | B-Cell Non-Hodgkin Lymphoma (NHL) | High-Grade B-Cell Lymphoma (HGBCL)
-
Marinus PharmaceuticalsTerminatedDrug Resistant Partial Onset SeizureUnited States
-
SymBio PharmaceuticalsCompletedLymphoma, B-cell, DiffuseJapan
-
Regeneron PharmaceuticalsTerminatedAllergic Rhinitis Due to Cat AllergyUnited States, Belgium, Germany, Poland, Canada, France
-
BioCryst PharmaceuticalsCompletedHereditary Angioedema | HAEUnited States, Austria, Canada, Czechia, France, Germany, Hungary, North Macedonia, Romania, Spain, United Kingdom
-
Allena PharmaceuticalsCompletedChronic Kidney Diseases | Hyperuricemia | GoutUnited States
-
Marinus PharmaceuticalsTerminated
-
Rigel PharmaceuticalsCompletedWarm Antibody Autoimmune Hemolytic AnemiaUnited States, Spain, Canada, Australia, Norway, France, Belarus, Germany, Netherlands, Belgium, United Kingdom, Austria, Czechia, Georgia, Italy, Russian Federation, Serbia, Ukraine, Romania, Denmark, Hungary, Bulgaria
-
Regeneron PharmaceuticalsCompletedHealthy VolunteerUnited Kingdom
-
Botanix PharmaceuticalsCompletedPrimary Axillary HyperhidrosisUnited States
-
Botanix PharmaceuticalsCompletedHyperhidrosisUnited States
-
Botanix PharmaceuticalsCompletedHyperhidrosisUnited States
-
Regeneron PharmaceuticalsCompletedHealthy ParticipantsUnited States, Moldova, Republic of, Romania
-
Jazz PharmaceuticalsCompletedPain | Multiple Sclerosis | SpasticityUnited Kingdom
-
Jazz PharmaceuticalsCompletedMultiple Sclerosis | SpasticityUnited Kingdom
-
Jazz PharmaceuticalsCompletedPain | CancerUnited Kingdom
-
Jazz PharmaceuticalsCompletedPain | Peripheral NeuropathyUnited Kingdom
-
Regeneron PharmaceuticalsCompleted
-
Santhera PharmaceuticalsNo longer availableLeber's Hereditary Optic Neuropathy
-
Bellicum PharmaceuticalsSuspendedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | Solid Tumor, Adult | HER-2 Gene Amplification | HER-2 Protein OverexpressionUnited States
-
Marinus PharmaceuticalsCompletedCDKL5 Deficiency DisorderUnited States, Australia, France, Israel, Italy, Poland, Russian Federation, United Kingdom
-
Jazz PharmaceuticalsCompleted
-
Jazz PharmaceuticalsCompleted
-
Jazz PharmaceuticalsCompletedEvaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Potent Inhibitor of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a CYP2C19...United Kingdom
-
Regeneron PharmaceuticalsTerminatedHypertriglyceridemiaUnited States, Germany, Netherlands, Canada
-
Marinus PharmaceuticalsCompletedEpilepsyUnited States, Italy
-
Marinus PharmaceuticalsCompletedPartial Epilepsy | Catamenial EpilepsyUnited States
-
Botanix PharmaceuticalsCompletedHyperhidrosisUnited States
-
Regeneron PharmaceuticalsTerminated
-
Regeneron PharmaceuticalsCompleted
-
Marinus PharmaceuticalsCompletedDrug Resistant Partial Onset SeizureUnited States, Australia, Russian Federation, Bulgaria, Germany, Poland
-
CStone PharmaceuticalsCompletedRelapsed or Refractory Acute Myeloid LeukemiaChina
-
Regeneron PharmaceuticalsCompletedHypercholesterolemiaUnited States, Spain, Australia, Netherlands, Japan, Jordan, Denmark, Israel, Sweden, South Africa, Canada, Austria, Czechia, France, Italy, New Zealand, Norway, Poland, Russian Federation, United Kingdom
-
Neurotech PharmaceuticalsCompletedMacular Telangiectasia Type 2United States, Australia, Germany
-
Neurotech PharmaceuticalsCompletedA Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol AMacular Telangiectasia Type 2United States, United Kingdom, Australia, France
-
Ferring PharmaceuticalsWithdrawn
-
Alexion PharmaceuticalsCompleted